Skip to main content
. 2022 Aug 6;16:11795549221110501. doi: 10.1177/11795549221110501

Figure 3.

Figure 3.

Efficacy stratified by PD-L1 score. Red, PD-L1+; blue, PD-L1−. (A) PFS of all study subjects, (B) OS of all study subjects, (C) PFS of TNBC subjects, (D) OS of TNBC subjects.

CI indicates confidence interval; HR, hazard ratio; OS, overall survival; PD-L1, programmed death-ligand 1; PFS, progression-free survival; TNBC, triple-negative breast cancer.